株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

臍帯血バンキングサービス市場(私立および公立臍帯血バンク):世界の業界分析、規模、シェア、成長、動向および予測

Cord Blood Banking Services Market (Private and Public Cord Blood Banks) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

発行 Transparency Market Research 商品コード 294618
出版日 ページ情報 英文 92 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
臍帯血バンキングサービス市場(私立および公立臍帯血バンク):世界の業界分析、規模、シェア、成長、動向および予測 Cord Blood Banking Services Market (Private and Public Cord Blood Banks) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日: 2013年12月16日 ページ情報: 英文 92 Pages
概要

当レポートでは、臍帯血バンキング市場について調査し、臍帯血バンキングサービスの現状と将来的展望、欧米、アジアなどの地域別動向、市場規模と将来予測、市場の機会などをまとめ、概略下記の構成で取り上げております。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 世界の臍帯血バンキングサービス市場概要

  • 市場動向と将来見通し
  • 成長促進因子
    • 臍帯血バンキング技術の進歩
    • 患者の意識向上により受入も広がる
  • 阻害因子
    • 臍帯血ユニットの不足
    • 費用抑制
    • 認定要件
    • 試験所と保管に関する厳しい要件
  • 機会
    • 様々な治療における臍帯血の応用の広がり
    • 新興市場における未開発の機会
  • 臍帯血バンキング使用に関する法規制動向
  • 現在および将来の臍帯血移植で治療可能な医学的症状
    • 標準的治療
    • 治験中の幹細胞治療
    • 実験的治療
    • 臍帯組織からの幹細胞における治験
  • ポーターズファイブフォースモデル
  • 市場の魅力度分析:地域別

第4章 世界の臍帯血バンキングサービス市場:保管方法別

  • 概要:現在の市場シナリオと将来の市場動向
  • 比較:私立と効率の臍帯血バンク
    • 市場収益:2011〜2019年

第5章 世界の臍帯血バンキングサービス市場:地域別

  • 概要:現在の市場シナリオと将来の市場動向
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域

第6章 提言

第7章 企業プロファイル

  • China Cord Blood Corporation
  • Cord Blood America, Inc.
  • Cord Blood Registry Systems, Inc.
  • Cordlife Group Ltd.
  • Cryo-Cell International, Inc.
  • Cryo-Save Group AV
  • NeoStem, Inc.
  • ViaCord, Inc.

図表

目次

Umbilical cord blood banking or cord blood banking is the practice of preserving blood from the umbilical cord for future use. Such preserved cord blood is used in medical therapies in similar fashion as that of stem cells derived from bone marrow. Cord blood banking is practiced for using the cord blood stem cells for the purpose or re-populating blood and treating various medical conditions. This report studies the current market condition and future potential for cord blood banking services.

Based on the types of banks that store cord blood, the global cord blood banking services market is classified into public cord blood banks and private cord blood banks. This report studies the current market competition and future growth of private and public cord blood banks in terms of revenue generation of such services (USD Million) for the period 2011 - 2019. The report also demonstrates the compounded annual growth rate (CAGR %) for each such service type for the forecast period 2013 - 2019 while considering 2012 as the base year.

Geographically, this report categorizes the global cord blood banking services market into four regions namely North America, Europe, Asia-Pacific and rest of the world. An analysis of the market size and future potential of public and private cord blood banks has been analysed for each of the four regional markets. A qualitative study of the various major countries in each of these regions has been included in the report.

The market overview section of the report includes the qualitative analysis of the overall market in terms of drivers, restraints and opportunities, various disease conditions treated and treatable from cord blood, regulatory framework, along with the Porter's five forces analysis and market attractiveness analysis. The report is concluded with the competitive landscape and profiling of some of the major cord blood banks located worldwide. Some of such cord blood banks profiled in the report include Cord Blood Registry Systems, Inc., Cord Blood America, Inc., NeoStem, Inc., Cryo-Cell International, Inc., China Cord Blood Corporation and ViaCord, Inc. among others.

The global cord blood banking services market is segmented as follows:

  • Based on Type of Service Vendor
    • Private cord blood banks
    • Public cord blood banks
  • Based on Geography
    • North America
      • United States
      • Canada
    • Europe
      • UK
      • Spain
      • France
      • Germany
      • Italy
      • Belgium
    • Asia-Pacific
      • India
      • China
      • Japan
      • Australia
      • New Zealand
      • Philippines
    • Rest of the World
      • Brazil
      • Argentina
      • Middle Eastern Countries
      • Russia

Table of Contents

Chapter 1 Introduction

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
  • 1.4 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Global Cord Blood Banking Services Market Overview

  • 3.1 Market Trends and Future Outlook
    • 3.1.1 Differentiation of Hematopoietic Progenitor Cell to Create Lineage of Blood Cells
  • 3.2 Growth Drivers
    • 3.2.1 Advancement in Cord Blood Banking Technology
    • 3.2.2 Rising Parental Awareness Will In-Turn Increase the Acceptance
  • 3.3 Restraints
    • 3.3.1 Lack of Cord Blood Units
    • 3.3.2 Cost Constraints
    • 3.3.3 Accreditation Requirements
    • 3.3.4 Strict Laboratory and Storage Requirements
  • 3.4 Opportunities
    • 3.4.1 Increase in Applications of Cord Blood Cells in Treatment of Various Therapies
    • 3.4.2 Presence of Untapped Opportunities in Emerging Economies
  • 3.5 Regulatory Status for Using Cord Blood Banking
    • 3.5.1 American Association of Blood Banks (AABB)
    • 3.5.2 American Association of Tissue Banks (AATB)
    • 3.5.3 Clinical Laboratory Improvement Amendments (CLIA)
    • 3.5.4 Foundation for the Accreditation of Cellular Therapy (FACT)
    • 3.5.5 FDA Biologics License Application (FDA BLA)
    • 3.5.6 Human Tissue Authority (HTA) - UK
    • 3.5.7 International Organization for Standardization (ISO)
    • 3.5.8 Joint Accreditation Committee - ISCT - EBMT (JACIE)
    • 3.5.9 NetCord
  • 3.6 Current and Future Medical Conditions Treatable with Cord Blood Transplant
    • 3.6.1 Standard Therapies
      • 3.6.1.1 Leukemias
      • 3.6.1.2 Lymphomas
      • 3.6.1.3 Blood Cell Proliferation Disorders
      • 3.6.1.4 Transplants for Inherited Diseases Affecting Immune System and Related Organs
      • 3.6.1.5 Transplants for Inherited Metabolic Conditions
    • 3.6.2 Stem Cell Therapies in Clinical Trials
      • 3.6.2.1 Auto-Immune Diseases
      • 3.6.2.2 Cardiovascular Diseases
      • 3.6.2.3 Neurologic Diseases
      • 3.6.2.4 Orthopedic Diseases
      • 3.6.2.5 Stem Cells & Gene Therapy for Inherited Disorders
      • 3.6.2.6 Becker Muscular Dystrophy
      • 3.6.2.7 Stem Cell Transplantation for Additional Inherited Disorders
      • 3.6.2.8 Stem Cell Transplantation for New Indications
    • 3.6.3 Experimental Treatments
    • 3.6.4 Clinical Trials with Stem Cells from Cord Tissue
  • 3.7 Porter's Five Forces Analysis for the Global Cord Blood Banking Services Market
    • 3.7.1 Bargaining Power of Suppliers
    • 3.7.2 Bargaining Power of Buyers
    • 3.7.3 Threat of New Entrants
    • 3.7.4 Threat of Substitutes
    • 3.7.5 Competitive Rivalry
  • 3.8 Market Attractiveness Analysis of the Global Cord Blood Banking Services Market, 2012

Chapter 4 Global Cord Blood Banking Services Market, by Storage Options, 2011 - 2019 (USD Billion)

  • 4.1 Overview - Current Market Scenario and Future Market Trends
    • 4.1.1 Global Cord Blood Banking Services Market, by Storage Options, 2011 - 2019 (USD Billion)
  • 4.2 Comparison: Private and Public Cord Blood Banks
    • 4.2.1 Private Cord Blood Banks
      • 4.2.1.1 Global Private Cord Blood Banks Market Revenue, 2011 - 2019 (USD Billion)
    • 4.2.2 Public Cord Blood Banks
      • 4.2.2.1 Global Public Cord Blood Banks Market Revenue, 2011 - 2019 (USD Billion)

Chapter 5 Global Cord Blood Banking Services Market, by Geography, Size and Forecast, 2011 - 2019 (USD Billion)

  • 5.1 Overview - Current Market Scenario and Future Market Trends
  • 5.2 North America
    • 5.2.1 North America Cord Blood Banking Services Market Revenue, by Storage Options, 2011 - 2019 (USD Billion)
    • 5.2.2 Private Cord Blood Banking
      • 5.2.2.1 North America Private Cord Blood Banking Services Market Revenue, 2011 - 2019 (USD Billion)
    • 5.2.3 Public Cord Blood Banking
      • 5.2.3.1 North America Public Cord Blood Banking Services Market Revenue, 2011 - 2019 (USD Billion)
    • 5.2.4 U.S. - Current Status and Future Scenario
    • 5.2.5 Canada - Current Status and Future Scenario
  • 5.3 Europe
    • 5.3.1 Private Cord Blood Banking
      • 5.3.1.1 Europe Private Cord Blood Banking Services Market Revenue, 2011 - 2019 (USD Billion)
    • 5.3.2 Public Cord Blood Banking
      • 5.3.2.1 Europe Public Cord Blood Banking Services Market Revenue, 2011 - 2019 (USD Billion)
    • 5.3.3 U.K. - Current Status and Future Scenario
    • 5.3.4 Spain - Current Status and Future Scenario
    • 5.3.5 France - Current Status and Future Scenario
    • 5.3.6 Germany - Current Status and Future Scenario
    • 5.3.7 Italy - Current Status and Future Scenario
    • 5.3.8 Belgium - Current Status and Future Scenario
  • 5.4 Asia-Pacific
    • 5.4.1 Asia-Pacific Cord Blood Banking Services Market Revenue, by Storage Options, 2011 - 2019 (USD Billion)
    • 5.4.2 Private Cord Blood Banking
      • 5.4.2.1 Asia-Pacific Private Cord Blood Banking Services Market Revenue, 2011 - 2019 (USD Billion)
    • 5.4.3 Public Cord Blood Banking
      • 5.4.3.1 Asia-Pacific Public Cord Blood Banking Services Market Revenue, 2011 - 2019 (USD Billion)
    • 5.4.4 India - Current Status and Future Scenario
    • 5.4.5 China - Current Status and Future Scenario
    • 5.4.6 Japan - Current Status and Future Scenario
    • 5.4.7 Australia - Current Status and Future Scenario
    • 5.4.8 New Zealand - Current Status and Future Scenario
    • 5.4.9 Philippines - Current Status and Future Scenario
  • 5.5 Rest of the World (RoW)
    • 5.5.1 RoW Cord Blood Banking Services Market Revenue, by Storage Options, 2011 - 2019 (USD Billion)
    • 5.5.2 Private Cord Blood Banking
      • 5.5.2.1 RoW Private Cord Blood Banking Services Market Revenue, 2011 - 2019 (USD Billion)
    • 5.5.3 Public Cord Blood Banking
      • 5.5.3.1 RoW Public Cord Blood Banking Services Market Revenue, 2011 - 2019 (USD Billion)
    • 5.5.4 Brazil - Current Status and Future Scenario
    • 5.5.5 Argentina - Current Status and Future Scenario
    • 5.5.6 Middle Eastern Countries - Current Status and Future Scenario
    • 5.5.7 Russia - Current Status and Future Scenario

Chapter 6 Recommendations

Chapter 7 Company Profiles

  • 7.1 China Cord Blood Corporation
    • 7.1.1 Company Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
    • 7.1.4 Recent Development
  • 7.2 Cord Blood America, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
    • 7.2.4 Recent Developments
  • 7.3 Cord Blood Registry Systems, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Cordlife Group Ltd.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies
  • 7.5 Cryo-Cell International, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Business Strategies
    • 7.5.4 Partnerships and Agreements
    • 7.5.5 Recent Developments
  • 7.6 Cryo-Save Group AV
    • 7.6.1 Company Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Business Strategies
    • 7.6.4 Recent Developments
  • 7.7 NeoStem, Inc.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Overview
    • 7.7.3 Business Strategies
    • 7.7.4 Recent Developments
  • 7.8 ViaCord, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Overview
    • 7.8.3 Business Strategies
    • 7.8.4 Collaboration
    • 7.8.5 Recent Developments

List of Figures

  • FIG. 1 Cord Blood Banking Services: Market Segmentation
  • FIG. 2 Global Cord Blood Banking Services Market, by Geography, 2012
  • FIG. 3 Differentiation of Hematopoietic Progenitor Cell to Create Lineage of Blood Cells
  • FIG. 4 Porter's Five Forces Analysis: Global Cord Blood Banking Services Market
  • FIG. 5 Market Attractiveness Analysis: Cord Blood Banking Services Market, 2012
  • FIG. 6 Global Private Cord Blood Banks Market Revenue, 2011 - 2019 (USD Billion)
  • FIG. 7 Global Public Cord Blood Banks Market Revenue, 2011 - 2019 (USD Billion)
  • FIG. 8 North America Private Cord Blood Banking Services Market Revenue, 2011 - 2019 (USD Billion)
  • FIG. 9 North America Public Cord Blood Banking Services Market Revenue, 2011 - 2019 (USD Billion)
  • FIG. 10 Europe Private Cord Blood Banking Services Market Revenue, 2011 - 2019 (USD Billion)
  • FIG. 11 Europe Public Cord Blood Banking Services Market Revenue, 2011 - 2019 (USD Billion)
  • FIG. 12 Asia-Pacific Private Cord Blood Banking Services Market Revenue, 2011 - 2019 (USD Billion)
  • FIG. 13 Asia-Pacific Public Cord Blood Banking Services Market Revenue, 2011 - 2019 (USD Billion)
  • FIG. 14 RoW Private Cord Blood Banking Services Market Revenue, 2011 - 2019 (USD Billion)
  • FIG. 15 RoW Public Cord Blood Banking Services Market Revenue, 2011 - 2019 (USD Billion)
  • FIG. 16 China Cord Blood Corporation: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 17 Cord Blood America, Inc.: Annual Revenue, 2010-2012 (USD Million)
  • FIG. 18 Cordlife Group Ltd.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 19 Cryo-Cell International, Inc.: Annual Revenue, 2010-2012 (USD Million)
  • FIG. 20 Cryo-Save Group AV: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 21 NeoStem, Inc.: Annual Revenue, 2010-2012 (USD Million)

List of Tables

  • TABLE 1 Standard Therapies Treatable with Cord Blood Transplant: Leukemias
  • TABLE 2 Standard Therapies Treatable with Cord Blood Transplant: Lymphomas
  • TABLE 3 Standard Therapies Treatable with Cord Blood Transplant: Blood Cell Proliferation Disorders
  • TABLE 4 Standard Therapies Treatable with Cord Blood Transplant: Transplants for Inherited Diseases Affecting Immune System and Related Organs
  • TABLE 5 Standard Therapies Treatable with Cord Blood Transplant: Transplants for Inherited Metabolic Conditions
  • TABLE 6 Stem Cell Therapies in Clinical Trials: Auto-Immune Diseases
  • TABLE 7 Stem Cell Therapies in Clinical Trials: Cardiovascular Diseases
  • TABLE 8 Stem Cell Therapies in Clinical Trials: Neurologic Diseases
  • TABLE 9 Stem Cell Therapies in Clinical Trials: Orthopedic Diseases
  • TABLE 10 Stem Cell Therapies in Clinical Trials: Stem Cells & Gene Therapy for Inherited Disorders
  • TABLE 11 Stem Cell Therapies in Clinical Trials: Becker Muscular Dystrophy
  • TABLE 12 Stem Cell Therapies in Clinical Trials: Stem Cell Transplantation for Additional Inherited Disorders
  • TABLE 13 Stem Cell Therapies in Clinical Trials: Stem Cell Transplantation for New Indications
  • TABLE 14 Experimental Treatments
  • TABLE 15 Clinical Trials with Stem Cells from Cord Tissue
  • TABLE 16 Global Cord Blood Banking Services Market, by Storage Options, 2011 - 2019 (USD Billion)
  • TABLE 17 Comparison: Private and Public Cord Blood Banks
  • TABLE 18 Global Cord Blood Banking Services Market Revenue, by Geography, 2011 - 2019 (USD Billion)
  • TABLE 19 North America Cord Blood Banking Services Market Revenue, by Storage Options, 2011 - 2019 (USD Billion)
  • TABLE 20 Europe Cord Blood Banking Services Market Revenue, by Storage Options, 2011 - 2019 (USD Billion)
  • TABLE 21 Asia-Pacific Cord Blood Banking Services Market Revenue, by Storage Options, 2011 - 2019 (USD Billion)
  • TABLE 22 RoW Cord Blood Banking Services Market Revenue, by Storage Options, 2011 - 2019 (USD Billion)
Back to Top